![]() |
市场调查报告书
商品编码
1898024
真空辅助乳房切片设备市场规模、份额及成长分析(按产品、类型、技术、应用、最终用户和地区划分)-2026-2033年产业预测Vacuum-Assisted Breast Biopsy Device Market Size, Share, and Growth Analysis, By Product (Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices), By Type, By Technique, By Applications, By End User, By Region - Industry Forecast 2026-2033 |
||||||
全球真空辅助乳房切片设备市场规模预计在 2024 年达到 9.0684 亿美元,从 2025 年的 10.1294 亿美元增长到 2033 年的 24.5475 亿美元,在预测期(2026-2033 年)内复合年增长率为 11.7%。
受乳癌发生率不断上升的推动,真空辅助乳房切片装置(VABB)市场正经历显着成长。乳癌是全球女性面临的主要健康问题之一。与传统诊断方法相比,VABB具有更快的周转时间和更高的便利性。它只需一次穿刺即可采集足够的组织样本,从而能够获得多个检体,有助于提高诊断的准确性。这降低了漏诊或组织学诊断不足的风险。由于乳癌是女性死亡的主要原因之一,公众意识的提高以及政府主导的早期检测措施预计将进一步推动对VABB的需求。这将巩固VABB作为现代乳癌诊断首选设备的地位。
全球真空辅助乳房切片设备市场驱动因素
与传统切片检查技术相比,真空辅助乳房切片装置(VABB)的日益普及主要归功于其能够透过单次穿刺高效采集多个连续组织样本。该技术不仅显着降低了漏诊癌症和组织学低估的发生率,提高了诊断准确性,而且还能够对纤维腺瘤等良性病变进行治疗性切除。此外,经皮VABB的使用减少了更具侵入性的开放式切片检查和切除手术的需求,从而降低了手术成本并缩短了住院时间。这些因素共同推动了全球VABB装置市场的成长。
全球真空辅助乳房切片设备市场面临的限制因素
全球真空辅助乳房切片设备市场受到该技术高昂的资本投入和营运成本的限制。这些设备需要真空产生器和专用切片检查牙科手机等昂贵的组件,以及针头、导管和定位标记等耗材的持续支出。因此,在许多医疗机构,真空辅助乳房切片检查通常作为辅助切片检查手段,仅用于细针穿刺切片检查(FNA) 或粗切片检查等领先技术效果不佳或影像学结果相互矛盾的情况。这一限制影响了真空辅助乳房切片在临床实践中的普及。
全球真空辅助乳房切片设备市场趋势
受微创技术进步和人们对乳癌早期检测日益增长的关注所驱动,全球真空辅助乳房切片市场正经历显着增长。广泛的研究环境推动更精准诊断解决方案的创新,同时政府大力支持加强癌症研究基础建设。这种有利的环境不仅促进了先进设备的研发,也鼓励了医疗专业人员和研究人员之间的合作。随着医疗保健系统越来越重视患者的舒适度和诊断的准确性,对真空辅助乳房切片活检设备的需求预计将持续增长,这反映了个人化医疗和早期疗育策略的更广泛趋势。
Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 906.84 Million in 2024 and is poised to grow from USD 1012.94 Million in 2025 to USD 2454.75 Million by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).
The vacuum-assisted breast biopsy (VABB) device market is experiencing significant growth, propelled by the increasing prevalence of breast cancer, a major health concern for women globally. VABB offers superior response times compared to traditional diagnostic methods, which enhances its appeal. Its ability to extract substantial tissue samples with a single needle insertion allows for multiple specimens and contributes to more accurate diagnoses, thereby reducing the likelihood of missed cancer cases and histological underestimations. With breast cancer being a leading cause of mortality among women, heightened awareness and governmental initiatives for early detection are expected to further fuel the demand for VABB devices, solidifying their position as a preferred choice in modern breast cancer diagnostics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vacuum-Assisted Breast Biopsy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vacuum-Assisted Breast Biopsy Device Market Segments Analysis
Global Vacuum-Assisted Breast Biopsy Device Market is segmented by Product, Type, Technique, Applications, End User and region. Based on Product, the market is segmented into Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Surgical Biopsy Devices and Others. Based on Type, the market is segmented into 9-12G, <9G and >12G. Based on Technique, the market is segmented into Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Others. Based on Applications, the market is segmented into Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Others. Based on End User, the market is segmented into Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vacuum-Assisted Breast Biopsy Device Market
The increasing adoption of vacuum-assisted breast biopsy (VABB) devices over traditional biopsy techniques is primarily due to their ability to obtain multiple contiguous tissue samples efficiently with a single needle insertion. This method not only enhances diagnostic accuracy by significantly lowering cancer miss rates and histological underestimates but also allows for therapeutic removal of benign lesions like fibroadenomas. Additionally, utilizing percutaneous VABB can diminish the necessity for more invasive open surgical biopsies or excisions, leading to reduced operating costs and shorter hospital stays. Collectively, these factors are propelling the growth of the VABB device market globally.
Restraints in the Global Vacuum-Assisted Breast Biopsy Device Market
The Global Vacuum-Assisted Breast Biopsy Device market faces constraints due to the substantial capital investment and operational expenditures associated with the technology. These devices require expensive components such as vacuum generators and specialized biopsy hand-pieces, along with ongoing costs for consumables like needles, tubing, and localizing markers. Consequently, VABB is frequently employed as a secondary biopsy option in various medical facilities, often reserved for situations where earlier methods, such as fine needle aspiration (FNA) or core biopsies, have proven insufficient or yielded conflicting results with imaging studies. This limitation impacts the overall adoption of VABB in clinical practice.
Market Trends of the Global Vacuum-Assisted Breast Biopsy Device Market
The Global Vacuum-Assisted Breast Biopsy Device market is experiencing significant growth, fueled by advancements in minimally invasive technologies and a heightened focus on early breast cancer detection. An expansive research landscape has led to the innovation of more precise diagnostic solutions, garnering strong support from government initiatives aimed at enhancing cancer research infrastructures. This conducive environment not only facilitates the development of sophisticated devices but also encourages collaborative efforts among healthcare professionals and researchers. As healthcare systems increasingly prioritize patient comfort and accurate diagnostics, the demand for vacuum-assisted breast biopsy devices is poised for continued expansion, reflecting broader trends in personalized medicine and early intervention strategies.